Cancer biology · 2026
How cancer develops:
six stages, one long window.
Cancer is not a sudden event — it builds over years through six stages, from a single gene mutation to invasion, metastasis and immune evasion. Understanding the sequence shows exactly where prevention, screening and early treatment can interrupt it.
Years
Not sudden
Multi-step process over time
Cancer biology
P53 / RAS
Key genes
Tumour-suppressor loss, oncogene activation
Molecular oncology
1–2 mm
Angiogenesis trigger
Tumour outgrows diffusion, recruits vessels
Tumour biology
VEGF
Angiogenic signal
Drives new blood-vessel growth
Tumour biology
PD-L1
Immune evasion
Switches off attacking T-cells
Immuno-oncology
Long window
For prevention
Screening catches early, curable disease
Preventive oncology
The key idea
A slow build,
not a switch.
The most important thing to understand about cancer is that it takes time. A normal cell does not become an invasive, life-threatening tumour overnight. It passes through a sequence of stages — each requiring a new capability — typically over years to decades.
That slow build is also our biggest opportunity. Because invasive cancer sits at the end of a long chain, there is usually a wide window beforehand in which the process can be caught or interrupted: reducing the exposures that cause mutations, screening to find precancer and early disease, and intensifying surveillance for those at high inherited risk.
Below we walk through the six stages — gene mutation, proliferation, micro-tumour, angiogenesis, invasion and metastasis, and immune evasion — and then map the prevention window each one opens. It is the biology behind our whole cancer-prevention and longevity-screening toolkit.
The process
Six stages of cancer development.
1 · Gene mutation
Environmental exposures, lifestyle factors or inherited defects damage DNA. When tumour-suppressors like P53 lose function and oncogenes like RAS activate, normal division and repair break down.
2 · Cell proliferation
The mutated cell divides without proper control, forming a colony of abnormal cells. At this point the lesion may still be benign — but it now carries the potential to progress.
3 · Micro-tumour formation
Millions of abnormal cells cluster into a small mass of roughly 1–2 mm. It is still restrained by surrounding normal tissue and not yet invasive — a key catchable stage.
4 · Microenvironment & angiogenesis
To grow further the tumour secretes growth factors such as VEGF, recruiting new blood vessels for oxygen and nutrients. This breaks tissue balance and lets the tumour expand rapidly.
5 · Invasion & metastasis
Cancer cells break through the basement membrane into blood and lymph, then seed distant organs — lung, liver, bone, brain — forming new tumours. This is what makes cancer lethal.
6 · Immune evasion
The tumour displays inhibitory signals like PD-L1 to block T-cell attack and recruits suppressive Tregs, so the immune system can no longer clear it — enabling long-term survival and spread.
The opportunity
A prevention window
at every stage.
Before mutation
Stop smoking, vaccinate against HPV and hepatitis B, manage alcohol, obesity and chronic inflammation — preventing the genetic damage that starts the whole sequence.
Precancer & micro-tumour
Colonoscopy, low-dose CT, cervical and breast screening and multi-cancer early-detection testing catch disease while it is local and curable — often before symptoms.
High inherited risk
For carriers of variants like TP53, intensified surveillance (whole-body and breast MRI, frequent review) shortens the window and catches cancers at the earliest possible stage.
Immune stage
Understanding immune evasion underpins modern immunotherapy — checkpoint inhibitors and therapeutic cancer vaccines such as WT1 — used in defined, evidence-based settings.
This page explains cancer biology for general understanding; it is not a diagnostic tool. The takeaway is practical: because cancer develops in stages over time, screening and risk-reduction genuinely change outcomes — which is what a structured prevention programme is built to deliver.
FAQ
How cancer develops, answered.
- Is cancer a sudden event or a gradual process?
- Gradual — almost always. Cancer is the end result of a multi-step process that typically unfolds over years to decades. A single cell accumulates genetic damage, begins to divide abnormally, forms a tiny cluster, recruits a blood supply, and only much later acquires the ability to invade and spread. This slow build is the single most important fact for prevention: it means there is usually a long window, before invasive cancer, in which screening can detect precancer or early disease and risk-reduction can interrupt the sequence.
- What starts the process — what is a gene mutation?
- The first stage is genetic damage. Mutations can be triggered by environmental exposures (chemicals, radiation, viral infection such as HPV or hepatitis B), lifestyle factors (smoking, poor diet, chronic stress and inflammation), or inherited gene defects. The damage matters when it hits the controllers of cell division — when tumour-suppressor genes like P53 (the 'guardian of the genome') lose function, or oncogenes like RAS become permanently switched on. That breaks the normal balance between cell division and repair.
- Why doesn't every mutated cell become cancer?
- Because the body has layered defences and cancer needs many things to go right (for the tumour) and wrong (for us). A single mutation is usually repaired or the cell self-destructs. Even when abnormal cells proliferate into a micro-tumour, they are initially held in check by surrounding tissue and cleared by the immune system. Cancer only emerges when a cell accumulates the full set of capabilities — sustained growth signals, a blood supply, invasiveness and immune evasion — across multiple steps. Each defence that holds is also a step prevention and treatment can reinforce.
- What is angiogenesis and why does it matter?
- Once a micro-tumour reaches roughly 1–2 millimetres, it can no longer get enough oxygen and nutrients by diffusion alone. To keep growing it secretes growth factors — notably VEGF (vascular endothelial growth factor) — that drive the formation of new blood vessels into the tumour. This angiogenesis is a turning point: it supplies the tumour to expand rapidly and also creates the vascular route cancer cells later use to spread. It is also a drug target — anti-angiogenic therapies aim to cut off this supply.
- How does cancer spread (metastasise)?
- In the invasion-and-metastasis stage, cancer cells break through the basement membrane and surrounding tissue structure and enter the bloodstream or lymphatic system. Carried through the body, some lodge in distant organs — commonly lung, liver, bone and brain — and establish new tumour deposits. Metastasis is what makes cancer dangerous: localised early-stage disease is often curable, while widespread metastatic disease is much harder to treat. This is precisely why catching cancer before this stage matters so much.
- What is immune evasion?
- The immune system constantly surveils for abnormal cells, and a successful cancer must escape it. Tumours do this by displaying inhibitory signals — for example PD-L1, which switches off attacking T-cells — and by recruiting immune-suppressive cells (regulatory T-cells, Tregs) that dampen the response. The result is that the immune system can no longer recognise and clear the cancer, allowing it to survive and spread. Understanding immune evasion is the basis of modern immunotherapy, including checkpoint inhibitors and therapeutic cancer vaccines.
- How does understanding these stages help prevention?
- Each stage is a potential intervention point. Before mutation: reduce exposure (stop smoking, vaccinate against HPV and hepatitis B, manage inflammation). At the precancer and micro-tumour stages: screening (colonoscopy, low-dose CT, cervical and breast screening) and multi-cancer early-detection testing can catch disease while it is still curable. For people with high inherited risk (e.g. a TP53 variant): intensified surveillance shortens the window further. The biology is the rationale for the whole prevention toolkit.
Continue exploring
Cancer Prevention Hub
The full prevention toolkit — risk testing, screening, immune options.
Back to hubCancer Statistics
China and Asia cancer burden, top cancers by sex, and age trends.
See the dataMulti-Cancer Early Detection
Catch a cancer signal early — before imaging or symptoms.
Read on MCEDTP53 Genetic Testing
The guardian-of-the-genome gene whose loss starts stage one.
Read on TP53WT1 Cancer Vaccine
Immunotherapy aimed at the immune-evasion stage — honestly graded.
Read on WT1Cancer Treatment in China
Surgery, radiation, chemotherapy and immunotherapy options.
See oncologyCatch it
in the window.
The biology is clear: cancer is most beatable before it invades and spreads. Tell us your age and risk profile and we’ll design a screening-and-prevention plan that works the window in your favour.